7 Results for "

SAM-binding pocket

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "SAM-binding pocket" in MCE Product Catalog:

Cat. No.: HY-163174
CAS No.: 2928480-72-0
Research Areas:  

Metabolic Disease Cancer

II399 is a nicotinamide N-methyltransferase (NNMT) inhibitor (human NNMT IC50 = 0.049-8.800 μM; Ki = 5.9-77 nM; Kd = 336 nM). II399 competitively blocks the transfer of methyl from SAM to nicotinamide by occupying the Nicotinamide (HY-B0150) and SAM binding pockets, and inhibits NNMT-mediated shunting of nicotinamide from the NAD + salvage pathway. II399 reduces cellular MNA, inhibits renal cancer cell viability, and in combination with SHMT2/MEPCE inhibits lipotoxicity and Cholesterol (from animal) (HY-N0322)-induced hepatocyte injury. II399 can be used for research on clear cell renal cell carcinoma and cholesterol-induced hepatotoxicity .
loading...
    loading...
Cat. No.: HY-155280
CAS No.: 331647-89-3
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-60 (compound 5a) is an S-adenosylmethionine (SAM)-competitive and irreversible SARS-CoV-2 nsp16-nsp10 methyltransferase activity inhibitor with an IC50 of 9 μM and a Ki of 26 μM. SARS-CoV-2-IN-60 can specifically occupy a newly identified pocket adjacent to the SAM-binding site on nsp16. SARS-CoV-2-IN-60 has the potential for pan-coronavirus therapeutics .
loading...
    loading...
Cat. No.: HY-134309
CAS No.: 61369-43-5
Target:  

Virus Protease

Research Areas:  

Infection

NSC 288387 is a pan-flavivirus MTase inhibitor. NSC 288387 binds to the SAM-binding pocket. NSC 288387 inhibits ZIKV with an IC50 of 0.2 μM. NSC 288387 also inhibits viral replication in cell culture .
loading...
    loading...
Cat. No.: HY-149005
CAS No.: 2783961-86-2
Research Areas:  

Cancer

PRMT5-IN-19 (Compound 41) is an selective orally active non-nucleoside PRMT5 inhibitor with IC50 values of 23.9 nM (radioactive biochemical assay) and 47 nM (AlphaLISA assay). PRMT5-IN-19 can occupy the SAM-binding pocket in PRMT5 and block methyltransferase activity, which displays good selectivity over other PRMTs and PKMTs. PRMT5-IN-19 inhibits cell proliferation by inducing cell apoptosis, and can be used for cancer-related research .
loading...
    loading...
Cat. No.: HY-181333
CAS No.: 2653338-74-8
Research Areas:  

Others

PROTAC EZH2 Degrader-38 (Compound 17) is a EZH2 PROTAC degrader with an IC50 of 165.00 nM. PROTAC EZH2 Degrader-38 functionally inhibits the methyltransferase activity of EZH2 and competitively binds to the SAM-binding pocket of the EZH2 SET domain .
loading...
    loading...
Cat. No.: HY-184653
Research Areas:  

Cancer

MS3-123 is an orally active PRMT1 inhibitor (IC50 = 11.4 nM) that selectively targets the unique Cys119 residue within the SAM-binding pocket. MS3-123 covalently binds to PRMT1 through a time-dependent irreversible mechanism and exhibits high selectivity over other PRMT family members and other methyltransferases. MS3-123 inhibits breast cancer cell proliferation, migration and invasion, and induces cell cycle arrest and apoptosis. MS3-123 is useful for breast cancer research .
loading...
    loading...
Cat. No.: HY-179556
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 nsp14-IN-10 is a highly potent and selective NSP14 (IC50 = 0.34 µM) S-adenosylmethionine (SAM) binding pocket inhibitor. SARS-CoV-2 nsp14-IN-10 demonstrates robust antiviral activity against SARS-CoV-2. SARS-CoV-2 nsp14-IN-10 exhibits broad-spectrum activity against other betacoronaviruses and inhibits SARS-CoV-2 at the replication stage. SARS-CoV-2 nsp14-IN-10 suppresses viral translation and exhibits immunostimulatory effects. SARS-CoV-2 nsp14-IN-10 specifically reverses NSP14-mediated alterations inhost transcriptome. SARS-CoV-2 nsp14-IN-10 can be used for the study of SARS-CoV-2 .
loading...
    loading...